Agency Information Collection Activities; Proposed eCollection eComments Requested; Special Agent Medical Preplacement-ATF Form 2300.10, 22444-22445 [2020-08509]

Download as PDF khammond on DSKJM1Z7X2PROD with NOTICES 22444 Federal Register / Vol. 85, No. 78 / Wednesday, April 22, 2020 / Notices to the ’397 and ’721 patents, and contingently petitioned for review of the final ID with respect to the ’818 patent. PTS did not file a petition for review, and, on June 25, 2019, PTS filed a response to ACON’s petition. On August 13, 2019, the Commission determined to review the Final ID in part. Specifically, the Commission determined to review the following issues: (1) Whether ACON Labs’ use of the accused products in the United States constitutes a violation of 19 U.S.C. 1337(a)(1)(B)(i); (2) the final ID’s construction of ‘‘reacting HDL . . . without precipitating said one or more non-selected analytes’’ in the ’721 patent, as well as related findings on infringement, the domestic industry, and invalidity; and (3) the final ID’s finding that all of the asserted claims of the ’721 patent are not shown to be invalid for a lack of enablement. The Commission did not review any other findings presented in the final ID. The Commission also sought briefing from the parties on four issues and on remedy, bonding, and public interest. On August 27, 2019, PTS and ACON filed their initial submissions in response to the Commission’s request for briefing. On September 3, 2019, PTS and ACON filed their reply submissions in response to the Commission’s request for briefing. No third-party submissions on remedy, bonding, or the public interest were received. Having examined the record of this investigation, including the Final ID, the petition, response, and other submissions from the parties, the Commission has determined that PTS has shown a violation of section 337 by ACON Bio and ACON Labs with respect to the ’397 and ’721 patents. The Commission has also determined to construe the term ‘‘precipitating’’ to mean ‘‘separating a solid substance or material from a solution by a chemical reaction,’’ and finds that, under this construction, PTS established infringement and the domestic industry requirement with respect to claims 1, 4, 6, 8, and 15 of the ’721 patent, and that ACON failed to show that any claim is invalid by clear and convincing evidence. The Commission’s determinations are explained more fully in the accompanying Opinion. All other findings in the ID under review that are consistent with the Commission’s determinations are affirmed. The Commission has determined that the appropriate form of relief in this investigation is a limited exclusion order with respect to ACON Bio and ACON Labs prohibiting the importation of imported blood cholesterol testing strips and associated systems containing VerDate Sep<11>2014 17:59 Apr 21, 2020 Jkt 250001 the same that are covered by one or more of claim 19 of the ’397 patent and claims 1, 4, 6, 8, and 15 of the ’721 patent. The Commission has further determined that the public interest factors enumerated in subsection 337(d)(1) (19 U.S.C. 1337(d)(1)) do not preclude the issuance of the limited exclusion order. Finally, the Commission has determined that the bond for importation during the period of Presidential review shall be in the amount of zero percent of the entered value of such articles. The Commission’s notice, order, and opinion were delivered to the President and to the United States Trade Representative on the day of their issuance. The Commission has also notified the Secretary of the Treasury and Customs and Border Protection of the order. The investigation is hereby terminated. The authority for the Commission’s determination is contained in section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and in part 210 of the Commission’s Rules of Practice and Procedure (19 CFR part 210). By order of the Commission. Issued: April 16, 2020. Lisa Barton, Secretary to the Commission. [FR Doc. 2020–08480 Filed 4–21–20; 8:45 am] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/ PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. SUPPLEMENTARY INFORMATION: Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Evaluate whether and if so how the quality, utility, and clarity of the information to be collected can be enhanced; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Bureau of Alcohol, Tobacco, Firearms and Explosives Overview of This Information Collection [OMB Number 1140–0056] (1) Type of Information Collection: Revision of a currently approved collection. (2) The Title of the Form/Collection: Special Agent Medical Preplacement. (3) The agency form number, if any, and the applicable component of the Department sponsoring the collection: Form number: ATF Form 2300.10. Component: Bureau of Alcohol, Tobacco, Firearms and Explosives, U.S. Department of Justice. (4) Affected public who will be asked or required to respond, as well as a brief abstract: Primary: Individuals or households. Other: Federal Government. Abstract: The Special Agent Medical Preplacement Form—ATF Form 2300.10 is used to collect specific personally identifiable information (PII), including the name, address, telephone, social security number and certain medical data. The collected medical data is used to determine if a candidate is medically Agency Information Collection Activities; Proposed eCollection eComments Requested; Special Agent Medical Preplacement—ATF Form 2300.10 Bureau of Alcohol, Tobacco, Firearms and Explosives, Department of Justice. ACTION: 30-Day notice. AGENCY: The Department of Justice (DOJ), Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF), will submit the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. DATES: Comments are encouraged and will be accepted for an additional 30 days until May 22, 2020. FOR FURTHER INFORMATION CONTACT: Written comments and SUMMARY: PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 E:\FR\FM\22APN1.SGM 22APN1 Federal Register / Vol. 85, No. 78 / Wednesday, April 22, 2020 / Notices qualified for and can be hired to serve as a criminal investigator (special agent) or an explosives enforcement officer. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: An estimated 288 respondents will utilize the form annually, and it will each respondents approximately 45 minutes for all respondents to prepare their responses. (6) An estimate of the total public burden (in hours) associated with the collection: The estimated annual public burden associated with this collection is 216 hours, which is equal to 288 (# of respondents) * 1 (number or responses per respondents) * .75 (45 minutes). (7) An Explanation of the Change in Estimates: The adjustments associated with this collection include an increase in both the number of respondents and total burden hours by 168 and 126 hours respectively, since the last renewal in 2017. Due to more respondents and an increase in the postal rate, the public cost has also increased by $2,160, since 2017. If additional information is required contact: Melody Braswell, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Two Constitution Square, 145 N Street NE, 3E.405A, Washington, DC 20530. Dated: April 17, 2020. Melody Braswell, Department Clearance Officer for PRA, U.S. Department of Justice. [FR Doc. 2020–08509 Filed 4–21–20; 8:45 am] BILLING CODE 4410–14–P DEPARTMENT OF JUSTICE Foreign Claims Settlement Commission [F.C.S.C. Meeting and Hearing Notice No. 03–20] khammond on DSKJM1Z7X2PROD with NOTICES Sunshine Act Meeting The Foreign Claims Settlement Commission, pursuant to its regulations (45 CFR part 503.25) and the Government in the Sunshine Act (5 U.S.C. 552b), hereby gives notice in regard to the scheduling of open meetings as follows: TIME AND DATE: Thursday, April 30, 2020, at 10:00 a.m. PLACE: This meeting will be held by teleconference. There will be no physical meeting place. STATUS: Open. Members of the public who wish to observe the meeting via teleconference should contact Patricia VerDate Sep<11>2014 17:59 Apr 21, 2020 Jkt 250001 M. Hall, Foreign Claims Settlement Commission, Tele: (202) 616–6975, two business days in advance of the meeting. Individuals will be given callin information upon notice of attendance to the Commission. MATTERS TO BE CONSIDERED: 10:00 a.m.—Issuance of Proposed Decisions under the Guam World War II Loyalty Recognition Act, Title XVII, Public Law 114–328. CONTACT PERSON FOR MORE INFORMATION: Requests for information, advance notices of intention to observe an open meeting, and requests for teleconference dial-in information may be directed to: Patricia M. Hall, Foreign Claims Settlement Commission, 441 G St. NW, Room 6234, Washington, DC 20579. Telephone: (202) 616–6975. Brian M. Simkin, Chief Counsel. [FR Doc. 2020–08585 Filed 4–20–20; 11:15 am] BILLING CODE 4410–BA–P DEPARTMENT OF JUSTICE [OMB Number 1122–0003] Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension of a Currently Approved Collection Office on Violence Against Women, Department of Justice. ACTION: 30-Day notice. AGENCY: The Department of Justice, Office on Violence Against Women (OVW) will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. DATES: Comments are encouraged and will be accepted for 30 days until May 22, 2020. FOR FURTHER INFORMATION CONTACT: Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/ PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. SUPPLEMENTARY INFORMATION: Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: SUMMARY: PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 22445 (1) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (2) Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) Enhance the quality, utility, and clarity of the information to be collected; and (4) Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of This Information Collection (1) Type of Information Collection: Extension of a currently approved collection. (2) Title of the Form/Collection: Annual Progress Report for the STOP Formula Grants Program. (3) Agency form number, if any, and the applicable component of the Department of Justice sponsoring the collection: Form Number: 1122–0003. U.S. Department of Justice, Office on Violence Against Women. (4) Affected public who will be asked or required to respond, as well as a brief abstract: The affected public includes the 56 STOP state administrators (from 50 states, the District of Columbia and five territories and commonwealths (Guam, Puerto Rico, American Samoa, Virgin Islands, Northern Mariana Islands)) and their subgrantees. The STOP Violence Against Women Formula Grants Program was authorized through the Violence Against Women Act of 1994 (VAWA) and reauthorized and amended by the Violence Against Women Act of 2000 (VAWA 2000) and by the Violence Against Women Act of 2005 (VAWA 2005). Its purpose is to promote a coordinated, multidisciplinary approach to improving the criminal justice system’s response to violence against women. The STOP Formula Grants Program envisions a partnership among law enforcement, prosecution, courts, and victim advocacy organizations to enhance victim safety and hold offenders accountable for their crimes of violence against women. OVW administers the STOP Formula Grants Program. The grant funds must be distributed by STOP state administrators to E:\FR\FM\22APN1.SGM 22APN1

Agencies

[Federal Register Volume 85, Number 78 (Wednesday, April 22, 2020)]
[Notices]
[Pages 22444-22445]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-08509]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Bureau of Alcohol, Tobacco, Firearms and Explosives

[OMB Number 1140-0056]


Agency Information Collection Activities; Proposed eCollection 
eComments Requested; Special Agent Medical Preplacement--ATF Form 
2300.10

AGENCY: Bureau of Alcohol, Tobacco, Firearms and Explosives, Department 
of Justice.

ACTION: 30-Day notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Justice (DOJ), Bureau of Alcohol, Tobacco, 
Firearms and Explosives (ATF), will submit the following information 
collection request to the Office of Management and Budget (OMB) for 
review and approval in accordance with the Paperwork Reduction Act of 
1995.

DATES: Comments are encouraged and will be accepted for an additional 
30 days until May 22, 2020.

FOR FURTHER INFORMATION CONTACT: Written comments and recommendations 
for the proposed information collection should be sent within 30 days 
of publication of this notice to www.reginfo.gov/public/do/PRAMain. 
Find this particular information collection by selecting ``Currently 
under 30-day Review--Open for Public Comments'' or by using the search 
function.

SUPPLEMENTARY INFORMATION: Written comments and suggestions from the 
public and affected agencies concerning the proposed collection of 
information are encouraged. Your comments should address one or more of 
the following four points:

--Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used;
--Evaluate whether and if so how the quality, utility, and clarity of 
the information to be collected can be enhanced; and
--Minimize the burden of the collection of information on those who are 
to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submission of responses.

Overview of This Information Collection

    (1) Type of Information Collection: Revision of a currently 
approved collection.
    (2) The Title of the Form/Collection: Special Agent Medical 
Preplacement.
    (3) The agency form number, if any, and the applicable component of 
the Department sponsoring the collection:
    Form number: ATF Form 2300.10.
    Component: Bureau of Alcohol, Tobacco, Firearms and Explosives, 
U.S. Department of Justice.
    (4) Affected public who will be asked or required to respond, as 
well as a brief abstract:
    Primary: Individuals or households.
    Other: Federal Government.
    Abstract: The Special Agent Medical Preplacement Form--ATF Form 
2300.10 is used to collect specific personally identifiable information 
(PII), including the name, address, telephone, social security number 
and certain medical data. The collected medical data is used to 
determine if a candidate is medically

[[Page 22445]]

qualified for and can be hired to serve as a criminal investigator 
(special agent) or an explosives enforcement officer.
    (5) An estimate of the total number of respondents and the amount 
of time estimated for an average respondent to respond: An estimated 
288 respondents will utilize the form annually, and it will each 
respondents approximately 45 minutes for all respondents to prepare 
their responses.
    (6) An estimate of the total public burden (in hours) associated 
with the collection: The estimated annual public burden associated with 
this collection is 216 hours, which is equal to 288 (# of respondents) 
* 1 (number or responses per respondents) * .75 (45 minutes).
    (7) An Explanation of the Change in Estimates: The adjustments 
associated with this collection include an increase in both the number 
of respondents and total burden hours by 168 and 126 hours 
respectively, since the last renewal in 2017. Due to more respondents 
and an increase in the postal rate, the public cost has also increased 
by $2,160, since 2017.
    If additional information is required contact: Melody Braswell, 
Department Clearance Officer, United States Department of Justice, 
Justice Management Division, Policy and Planning Staff, Two 
Constitution Square, 145 N Street NE, 3E.405A, Washington, DC 20530.

    Dated: April 17, 2020.
Melody Braswell,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2020-08509 Filed 4-21-20; 8:45 am]
 BILLING CODE 4410-14-P